What the buyer wrote
NHSBT is looking to award a Managed Service Contract for the supply of commercially available automated blood group testing equipment for use as a secondary testing technology for ABO and Rh D typing, antibody screening and identification, extended red cell phenotyping and HbAS (heterozygous sickle cell trait) screening for donor blood, tissues and stem cell (haemopoietic progenitor cells and therapeutic cells) samples.
Bid for this and lost? There is a short window in which the decision can be questioned.
Awarded to
Supplier not named
Details
- What the buyer calls it
- Secondary Blood Grouping and Sickle Testing
- How they are buying
- Advertised, open to anyoneAny supplier could bid without being invited first.
- Type
- services
Who the buyer named
The buyer published a contact address on this notice.
